Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect of Single Ascending Doses of TRX-100 in Healthy Volunteers
Conditions
Interventions
TRX-100 or placebo
Locations
1
Australia
Scientia Clinical Research Ltd.
Randwick, New South Wales, Australia
Start Date
March 25, 2026
Primary Completion Date
September 1, 2026
Completion Date
February 1, 2027
Last Updated
April 13, 2026
NCT00104325
NCT03878121
NCT00090662
NCT07310264
NCT06342713
NCT06223555
Lead Sponsor
Traws Pharma, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions